Author: Reviora Healthcare LLC

Revenue Growth Partner for US Medical Practices | Revenue Intelligence | AR Optimization | Denial Pattern & Root Cause Analysis 📩 DM for FREE Revenue Assessment

Chronic Care Management Billing: The Compliance Rules Practices Overlook

Posted on by Reviora Healthcare LLC in Newsletter

Reviora Healthcare LLC | Guaranteed Revenue Partner

Medicare has already clawed back $1.9 million from 50,192 chronic care management claims — and that was just one audit cycle. In 2026, OIG opened a fresh, multi-year review of CCM billing specifically targeting whether your patients even qualify. If your practice runs CCM and nobody’s double-checking eligibility documentation, you’re not managing a revenue stream — you’re carrying an open liability.

What does Medicare actually require to bill CCM?

CMS pays CCM under CPT 99490 for at least 20 minutes of clinical staff time per calendar month, directed by a physician or qualified practitioner, for a patient with two or more chronic conditions expected to last 12+ months or until death. The requirements are specific: two or more chronic conditions expected to last at least 12 months or until the patient’s death, conditions that place the patient at significant risk of death, acute exacerbation, or functional decline, and a comprehensive care plan that’s established, implemented, revised, or monitored (CMS, MLN Booklet, 2025). The time has to come from an eligible initiating visit — an E/M encounter, Annual Wellness Visit, or Initial Preventive Physical Exam — and the patient’s problems, medications, and allergies must live in certified EHR technology accessible to every staff member counting toward that 20 minutes (CMS, Chronic Care Management Checklist, November 2023). Miss any one piece, and the claim isn’t compliant, even if the time was genuinely spent.

Why is CCM one of Medicare’s highest-risk billing categories right now?

Because the error pattern is already documented at scale. In its 2021 audit of 2017–2018 claims, OIG found $1.9 million in overpayments across 50,192 claims, with 38,447 of those claims resulting from providers billing noncomplex or complex CCM more than once for the same beneficiary in the same service period, and another 10,882 claims stemming from CCM billed alongside overlapping care management services for the same patient (HHS-OIG, Report A-07-19-05122, August 2021). Beneficiaries themselves were overcharged up to $540,680 in cost-sharing as a direct result (HHS-OIG, Report A-07-19-05122, August 2021). These weren’t fraud rings. They were duplicate billing and overlapping-code errors — the kind that happen when nobody’s cross-checking the calendar month before submission.

What triggered OIG’s new 2026 audit, and why does it matter to you?

Because Medicare Part B payments for CCM services increased substantially from calendar year 2019 through 2024, and OIG is now reviewing whether the beneficiaries billed for CCM actually meet the multiple-chronic-conditions requirement (HHS-OIG Work Plan, announced March 16, 2026). This audit is scheduled to run through an estimated FY2028 completion. Translation: eligibility documentation — not just time logs — is the current federal scrutiny target. If your care plans don’t clearly show two qualifying conditions with the required risk profile, that’s the exact gap examiners are now built to find.

What internal controls actually prevent these errors?

A hard rule that only one practitioner can bill CCM for a patient per calendar month, checked before every submission — not after. CMS’s own provider checklist requires informing patients that only one practitioner can furnish and bill CCM during a calendar month, and that consent must be documented in the medical record (CMS, Chronic Care Management Checklist, November 2023). A minute-by-minute time log tied to named staff, not a monthly estimate reconstructed after the fact. And a claims edit process that flags a second CCM claim for the same beneficiary before it goes out the door — the exact failure CMS itself admitted it lacked during the audited period (HHS-OIG, Report A-07-19-05122, August 2021).

How Reviora keeps CCM billing audit-ready

This is where Expert-Led Technology earns its name — human specialists, not software alone, reviewing eligibility and time documentation before every CCM claim leaves the building. Our Medical Billing & Coding and Claims Submission & Denial Management teams build the duplicate-billing and eligibility checks directly into the pre-submission workflow, and every engagement runs under our Managed Outcomes Agreement — a written performance framework with the Benchmark Recovery Protocol activating automatically if standards slip two months running. If CCM sits inside a broader chronic-disease population, our Primary Care RCM team applies the same discipline across every recurring code, not just CCM.

If your CCM program hasn’t had a documentation review since before March 2026, that’s worth a conversation. Book a 30-minute consultation and we’ll walk through where your current process stands against what OIG is now actively auditing.

FAQ

Can CCM be billed without the patient signing a consent form?
Consent must be documented in the patient’s record, though it can be verbal or written; what matters to auditors is that it’s documented, not the format (CMS, Chronic Care Management Checklist, November 2023).

How many minutes per month does CCM actually require?
At least 20 minutes of clinical staff time in a single calendar month for CPT 99490 — time doesn’t carry over between months (CMS, MLN Booklet, 2025).

Can two different providers bill CCM for the same patient in the same month?
No. Only one practitioner may furnish and bill CCM services per beneficiary per calendar month, and billing for overlapping care management is one of the two largest error categories OIG identified in its audit (HHS-OIG, Report A-07-19-05122, August 2021).

Why is OIG auditing chronic care management in 2026?
Because Medicare Part B CCM payments grew substantially from 2019 through 2024, prompting a new multi-year review of whether billed patients meet the multiple-chronic-conditions eligibility requirement (HHS-OIG Work Plan, announced March 16, 2026).

Reference

Behavioral Health Claim Denials: The Documentation Gap Nobody Talks About

Posted on by Reviora Healthcare LLC in Newsletter

Reviora Healthcare LLC | Guaranteed Revenue Partner

Every denied behavioral health claim is a session you already delivered, staff hours you already paid for, and revenue that may never come back. Multiply that by a caseload running dozens of therapy and psychiatry visits a week, and a “small” documentation habit can quietly cost a practice tens of thousands of dollars a year — money that’s gone whether or not you ever notice it left.

Why do behavioral health claims get denied more than other specialties?

Because behavioral health is judged session by session, not diagnosis by diagnosis. In most of medicine, a diagnosis sets the treatment plan and individual visits get lighter scrutiny. In behavioral health, payers re-evaluate medical necessity almost every time — is this level of care still justified, is the patient still functionally impaired, is progress being made or not. That repeated scrutiny is exactly where thin documentation gets exposed.

Practice leaders are already feeling the trend line move the wrong way. In a March 2024 MGMA Stat poll, 60% of medical group leaders said their denial rates had increased compared to the same period the year before, with only 11% seeing improvement (MGMA Stat, March 2024). MGMA’s broader DataDive Practice Operations benchmarking put the single-specialty aggregate first-submission denial rate at 8%, unchanged from 2019 — meaning the industry hasn’t gotten meaningfully better at this in half a decade (MGMA DataDive Practice Operations, 2023 dataset).

What’s the real documentation gap driving these denials?

The gap is between what a clinician knows to be true and what a reviewer is trained to look for. A progress note can accurately describe a good session and still fail medical necessity review if it doesn’t tie back to a measurable treatment goal, document functional impairment, or justify why this level of care — versus a lower one — is still appropriate.

This isn’t a behavioral health–only problem, but it hits behavioral health hardest because so much of the specialty runs on prior authorization and continued-stay review. The American Medical Association’s 2024 Prior Authorization Physician Survey of 1,000 practicing physicians found that 93% say prior authorization delays access to necessary care, and 82% say it sometimes leads patients to abandon treatment altogether (AMA, 2024). Physicians in the survey reported completing an average of 39 prior authorization requests per week, consuming roughly 13 staff hours — a workload most solo and small behavioral health practices simply don’t have the back-office capacity to absorb (AMA, 2024).

Why isn’t “just automate it” the fix?

Because most of the industry hasn’t automated the part that actually matters. The 2024 CAQH Index found that only 35% of medical prior authorizations are completed fully electronically using the standard X12 278 transaction — the rest still run through portals, faxes, and phone calls (CAQH Index, 2024). And from the provider’s side, a manual prior authorization transaction costs $10.97, versus $5.79 when it’s processed electronically — nearly double, per CAQH’s own benchmarking (CAQH Index, 2023). Automation helps with speed and cost. It does nothing for a note that doesn’t demonstrate medical necessity in the first place — that’s a clinical documentation and workflow problem, not a software problem.

What does a defensible behavioral health claim actually require?

It requires the note to answer the payer’s question before they ask it. That means a diagnosis, a treatment plan with measurable goals, documented functional impairment, and a clear clinical rationale for the frequency and intensity of care — written in a way a utilization reviewer who has never met your patient can still follow.

Most practices don’t lack good clinicians. They lack a system that catches the gap between the chart and the payer’s checklist before the claim goes out — not after the denial comes back.

Closing the gap: expert-led, not software-led

At Reviora, we don’t sell software that promises to fix this on autopilot. Our model is Expert-Led Technology: credentialed billing and coding specialists review claims and documentation patterns before submission, with technology supporting their work rather than replacing their judgment. For clients, this is formalized in a Managed Outcomes Agreement (MOA) — a written contract built around five performance benchmarks — backed by a Benchmark Recovery Protocol (BRP) that activates automatically if two consecutive months miss those benchmarks. Documentation gaps get caught and corrected on a schedule, not discovered in a denial report three months later.

If your behavioral health practice is watching denial rates creep upward and can’t tell whether it’s a coding issue, a documentation issue, or a payer issue, that diagnostic conversation is worth having before it costs another quarter of revenue. Book a free 30-minute consultation and we’ll walk through where your claims are actually getting stopped.

FAQ

Why do behavioral health claims get denied for medical necessity? Because payers reassess medical necessity at the session or continued-stay level, not just at diagnosis, and most clinical notes are written for clinical continuity rather than for a utilization reviewer’s checklist.

What documentation do payers require for mental health prior authorization? Generally a current diagnosis, a treatment plan with measurable and time-bound goals, evidence of functional impairment, and a clinical rationale for the requested frequency, duration, and level of care.

How many prior authorizations does the average practice handle each week? Physicians surveyed by the AMA in 2024 reported completing an average of 39 prior authorization requests per week, consuming about 13 staff hours (AMA, 2024).

Does the Mental Health Parity Act stop behavioral health denials? The Mental Health Parity and Addiction Equity Act requires insurers to apply comparable coverage criteria to behavioral health and medical/surgical benefits, but it doesn’t eliminate medical necessity review — it gives practices grounds to appeal when that review is applied unevenly.

Reference

Telehealth Billing for OB/GYN in 2026: What’s Reimbursable and What Isn’t

Posted on by Reviora Healthcare LLC in Newsletter

Reviora Healthcare LLC | Guaranteed Revenue Partner

One denied telehealth claim rarely sinks a practice. A pattern of them does — and OB/GYN groups are walking into 2026 with three moving targets at once: a new CMS fee schedule, an ACOG-recommended modifier transition, and a 2027 coding overhaul already reshaping how payers review claims today. Bill the wrong visit type or skip the wrong modifier, and that “quick virtual check-in” turns into a 30-, 60-, or 90-day AR problem you didn’t budget for.

Did Medicare telehealth coverage actually get extended for 2026?

Yes — Section 6209 of the Consolidated Appropriations Act, 2026 (H.R. 7148), signed into law on February 3, 2026, extended the major COVID-era Medicare telehealth flexibilities through December 31, 2027. That followed a real lapse: these flexibilities expired on January 30, 2026, after already having briefly expired once during the fall 2025 government shutdown, so this wasn’t a routine renewal — it was a fix after two live disruptions in five months. Home remains an approved originating site, geographic restrictions stay waived, and audio-only visits continue to be covered for non-behavioral-health services, per CMS’s own telehealth guidance.

For OB/GYN practices, that back-and-forth is the real lesson. Practices that pulled patients off telehealth during the January lapse — unsure whether claims would be paid — now have a longer runway, but the pattern shows this isn’t a settled policy. It’s a recurring renewal risk your billing workflow needs to be built to withstand, not just react to.

The CY 2026 Medicare Physician Fee Schedule Final Rule also made several telehealth provisions permanent rather than year-by-year renewals. CMS streamlined how services get added to the Medicare Telehealth Services List and removed frequency limits on certain follow-up visit types. Translation: fewer annual surprises, but the rules that remain still have to be coded correctly the first time.

Is telehealth reimbursable for routine prenatal visits?

It depends entirely on how your practice bills obstetric care, and that’s the part most administrators miss. CMS’s Physician Fee Schedule primarily governs Medicare, and Medicare does not typically cover routine prenatal care for most patients — the telehealth flexibilities above matter most for your commercial and Medicaid payers, whose policies vary by state and plan. Where a payer does recognize telehealth for antepartum visits, ACOG recommends appending HCPCS modifier TH to the E/M code so the payer can distinguish it as maternity-related care, not a routine office visit.

That modifier isn’t optional housekeeping. ACOG has told plans to begin transitioning to individual E/M codes for antepartum visits — separate from the bundled global package — no later than September 1, 2026, ahead of the AMA’s broader 2027 restructuring of maternity CPT codes. Practices that keep billing prenatal telehealth visits the old way, folded into the global package, risk both underpayment and denials as payers start testing for the TH modifier this year.

What’s changing with the 2027 global maternity overhaul — and why does it matter now?

The AMA CPT Editorial Panel, working with ACOG, approved a full restructuring of maternity coding that retires the bundled global obstetric package effective January 1, 2027, replacing it with separate codes for antepartum, labor management, delivery, and postpartum care. AMA has stated the new framework is designed partly to support telehealth and home monitoring as legitimate, separately reportable components of prenatal care rather than an ambiguous add-on to a flat-fee package.

That’s good news long-term, but 2026 is the transition runway. Any OB/GYN practice still billing telehealth visits as an undocumented extra inside the global fee is building workflows that won’t survive the switch — and payers are already recalibrating their edits in anticipation.

What about postpartum depression screening and other non-obstetric GYN visits?

Audio-only and audio-video telehealth visits for postpartum mental health support remain reimbursable in 2026 under the extended Medicare flexibilities, and most commercial plans have followed suit given the clinical urgency of postpartum depression screening. Standard GYN follow-up visits — medication management, results review, low-acuity symptom checks — generally qualify too, provided the payer’s telehealth policy covers the specific CPT/E/M code billed.

The catch is documentation, not eligibility. A telehealth visit billed under the wrong place-of-service code, or missing the modifier your payer requires (95, GT, or the newer audio-only codes depending on payer), gets flagged as a technical denial even when the clinical service itself was fully covered.

What’s simply not reimbursable in OB/GYN telehealth right now?

Procedures requiring hands-on examination — colposcopy, in-office ultrasound, most surgical follow-ups needing physical assessment — aren’t telehealth-eligible under any current payer policy, CMS included. Billing an E/M telehealth code for a visit that should have been an in-person procedural visit is one of the fastest routes to a payer audit, not just a denial.

Layering routine prenatal E/M visits on top of an already-billed global obstetric package is the second common trap — those visits are already paid inside codes like 59400 or 59510, and double-billing them invites recoupment, not just rejection.

The bottom line for your practice

None of this requires guesswork if your billing team is tracking payer-specific telehealth policy, modifier requirements, and the 2027 runway simultaneously. That’s exactly the kind of detail work that erodes a practice’s Clean Claim Rate and First Pass Resolution Rate when it’s handled reactively instead of built into the workflow from the start.

This is where Expert-Led Technology earns its name — credentialed specialists who know payer-specific telehealth rules cold, supported by systems that catch a missing modifier before the claim goes out, not after the denial comes back. Reviora’s OB/GYN Specialty RCM service works alongside your Claims Submission & Denial Management team to keep telehealth billing aligned with both current CMS policy and the 2027 transition — backed by the accountability structure laid out in The Reviora Guarantee.

If your telehealth claims have been inconsistent, it’s worth a conversation before the 2027 changes compound the problem. Book a free 30-minute consultation and we’ll walk through where your current workflow stands.

FAQ

Does Medicare cover telehealth for OB/GYN visits in 2026? Yes, for eligible non-behavioral-health services, through December 31, 2027, under the Consolidated Appropriations Act, 2026 — but Medicare doesn’t typically cover routine prenatal care for most patients, so commercial and Medicaid telehealth policies matter more for maternity care specifically.

What modifier do I use for OB telehealth visits in 2026? ACOG recommends the HCPCS modifier TH on E/M codes to identify maternity-related visits, in addition to whatever telehealth modifier (95, GT, or audio-only codes) your specific payer requires.

Will telehealth reimbursement rules change again before 2027? The major Medicare flexibilities are now locked in through December 31, 2027, but the January 1, 2027 AMA CPT restructuring of maternity codes will change how OB telehealth visits are billed regardless of the telehealth policy itself.

Can I bill a telehealth visit on top of the global maternity package? No — routine antepartum visits are already paid inside the global code; billing them separately, by telehealth or otherwise, is a leading cause of payer audits and recoupment in OB billing.

Reference

Why Wound Care Claims Keep Getting Denied (And What Actually Fixes It)

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

Every denied wound care claim is a bill you already paid — staff time, supplies, clinician hours — with no revenue attached to it. Rework it, and you’re paying twice: once to deliver the care, once to fight for payment on care you already delivered. For a specialty running on thin margins and expensive biologics, that math adds up fast.

Why is wound care coding so denial-prone?

Because almost nothing about it is standardized. Debridement codes are depth-dependent — CPT 11042, 11043, and 11044 depend on the deepest tissue layer removed, not how the wound looks on the surface. Diabetic ulcers typically require dual ICD-10 codes covering both the wound and its underlying cause. Compression and debridement performed on the same limb can trigger bundling edits. One mismatch between depth documentation and the code billed is enough to generate a denial — and wound care has more of these decision points per claim than almost any other specialty.

Why do so many wound care claims stall on prior authorization?

Because skin substitutes, biologics, and negative pressure wound therapy routinely require it, and prior auth is now a documented drag on care nationally. In the American Medical Association’s 2024 Prior Authorization Physician Survey — 1,000 practicing physicians surveyed in December 2024 — prior authorization is described as a cost-control process requiring advance health-plan approval before treatment qualifies for coverage, and separately, 92% of physicians report care delays tied to prior authorization. Every day a graft or biologic sits in PA review is a day of clinical urgency working against your claim, not for it.

What changed for wound care reimbursement in 2026?

CMS overhauled how skin substitutes get paid, and it took effect January 1, 2026. Under the prior model, each skin substitute product had its own billing code and its own average-sales-price-based payment limit — a system CMS says drove Medicare Part B spending on these products from $252 million in 2019 to over $10 billion in 2024, a nearly 40-fold increase. In the CY 2026 Medicare Physician Fee Schedule Final Rule, CMS finalized a single flat payment rate of approximately $127.28 per square centimeter for most skin substitute products, replacing that per-product ASP pricing. If your billing workflow — or your formulary — still assumes the old per-product logic, every claim built on it is now a denial or audit risk.

Is this really worse than other specialties, or does it just feel that way?

It’s a fair question, and the honest answer is: the industry doesn’t yet publish a wound-care-specific denial rate from a primary source like MGMA or HFMA — most of what circulates is billing-vendor marketing, not benchmarking data. What is documented is the trend line for everyone: MGMA’s DataDive Practice Operations benchmarking put the single-specialty aggregate first-submission denial rate at 8% as of 2023, unchanged from 2019, while more recent MGMA figures cited by HFMA show over half of healthcare organizations now report denial rates exceeding 10%. Wound care sits on top of that baseline with three extra layers most specialties don’t carry at the same time: depth-dependent coding, near-universal prior auth on advanced therapies, and a reimbursement model CMS just rebuilt from the ground up.

How do you actually fix this?

You stop treating wound care like a documentation problem and start treating it like a specialty problem. That means claims scrubbed by people who know the difference between a 15271 and a 15275 before submission, not after denial. It means prior authorizations tracked and chased the same day a biologic is ordered, not the day the claim bounces. And it means a billing partner who rebuilt their coding logic around the CMS 2026 rate before January 1 — not the week after a wave of denials hit.

That’s the model behind Reviora’s Specialty-Specific RCM approach: Expert-Led Technology — credentialed specialists make the coding and appeals calls, software supports their judgment rather than replacing it. It’s also why our Managed Outcomes Agreement exists: a written performance agreement with a built-in accountability mechanism if results slip for two consecutive months, so “trust us” isn’t the whole pitch.

If your wound care claims are aging out faster than they used to, don’t wait for Q1 close to find out why. Book a 30-minute consultation and we’ll walk through your denial patterns together — no obligation, no sales pitch.

FAQ

Why do wound care claims get denied so often? Wound care combines depth-dependent coding, dual-diagnosis requirements for chronic wounds, and near-universal prior authorization on biologics and advanced therapies — more failure points per claim than most other specialties, compounded by a 2026 CMS reimbursement overhaul many practices haven’t fully adapted to yet.

What is the 2026 CMS skin substitute payment rule? Effective January 1, 2026, CMS replaced the old product-specific ASP-based payment model for most skin substitutes with a single flat national rate of about $127.28 per square centimeter, finalized in the CY 2026 Medicare Physician Fee Schedule Final Rule.

Do wound care claims need prior authorization? Often, yes — particularly for skin substitutes, biologics, and negative pressure wound therapy under commercial payers and some Medicare Advantage plans. Per the AMA’s 2024 Prior Authorization Physician Survey, most physicians report the process delays patient care.

How can I reduce wound care claim denials? Focus on pre-submission coding accuracy (especially debridement depth and dual ICD-10 pairing), get prior authorizations moving the day treatment is ordered, and confirm your formulary and billing logic reflect the 2026 CMS flat-rate skin substitute policy.

Reference

5 Places Your Practice May Be Losing Revenue

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

Your P&L can look fine on the surface and your practice can still be bleeding five or six figures a year — quietly, in places nobody reviews on a Tuesday afternoon. Revenue leakage rarely shows up as one dramatic loss. It shows up as a dozen small ones: a denied claim nobody re-worked, a payer that took 45 days too long, a copay nobody asked for. By the time it’s visible on a financial statement, it’s already gone.

Here are five places specialty practices lose money most often — and what the data says about each one.

Are claims getting denied before they ever reach the payer?

Denials are the most visible leak, and they’re getting worse, not better. A March 2024 MGMA Stat poll found that 60% of medical group leaders reported an increase in their practices’ claim denial rates compared to the same period the year before. MGMA’s own DataDive Practice Operations data set put the single-specialty aggregate first-submission denial rate at 8% — a number that has barely moved since 2019.

Every denied claim means rework: a coder or biller has to stop, investigate, correct, and resubmit — work that costs staff time whether or not the claim ever gets paid. The practices bucking the trend aren’t working denials harder; they’re preventing them earlier, at intake and coding, before the claim ever leaves the building.

Is your money sitting in AR instead of your bank account?

Days in AR is the clearest signal of how fast your practice actually gets paid — and most practices don’t like what it tells them. HFMA’s MAP Keys, the industry-standard benchmark used across revenue cycle management, set the target range for net days in AR at 30 to 40 days, with accounts over 90 days ideally kept below 10% of total receivables.

Every extra week a claim sits unworked is a week that money isn’t funding payroll, supplies, or growth. AR that drifts past 60 or 90 days isn’t just slow — it’s a strong predictor that a percentage of it will never be collected at all.

Is prior authorization quietly consuming your staff’s week?

Prior auth isn’t just a clinical headache — it’s a direct revenue cycle cost. The AMA’s most recent Prior Authorization Physician Survey found that 95% of physicians report prior authorization delays access to necessary care, and 88% say it drives higher overall utilization and administrative waste. Separately, CAQH’s 2024 Index found that only 35% of medical prior authorizations are conducted fully electronically — meaning most of that burden still runs through phone calls, faxes, and payer portals.

That’s staff time spent chasing approvals instead of working denials, verifying eligibility, or following up on aged claims — and it’s one of the most under-measured drains on a specialty practice’s revenue cycle.

Is a credentialing delay keeping a provider from billing at all?

This one doesn’t show up as a denial — it shows up as revenue that was never billable in the first place. A November 2025 MGMA Stat poll found that 32% of medical groups reported some form of credentialing backlog: files stalled, CVO delays, or completions slipping into the following quarter.

A provider who isn’t credentialed and enrolled can’t bill in-network, no matter how many patients they see. For specialty practices bringing on new physicians or renewing existing panels, a stalled file is unbillable clinical time — every single day it sits open.

Are you leaving patient balances on the table at check-out?

Point-of-service collection has quietly gotten worse across the industry. MGMA’s single-specialty Practice Operations data showed the percentage of copayments collected at time of service fell to 56% in 2022, down from 89.9% in 2019 — a swing that reflects both rising patient financial responsibility and looser front-desk collection habits.

Every dollar not collected at check-out becomes a statement, then a follow-up call, then — often — a write-off. It’s the cheapest dollar your practice will ever collect, and it’s the one most often skipped.

What this adds up to

None of these five leaks are dramatic on their own. Together, they’re often the difference between a practice that’s merely surviving and one that’s actually growing. This is exactly why Reviora built the Managed Outcomes Agreement (MOA) — a written performance agreement covering the benchmarks that matter most across denials, AR, and collections — backed by the Benchmark Recovery Protocol, which activates automatically if performance slips for two consecutive months. It’s Expert-Led Technology: our specialists own the outcome, and the technology supports the work rather than replacing the judgment behind it.

If you want a clearer picture of where your own practice is leaking revenue, we’ll walk through it with you — no sales pitch, just a look at your numbers. Book a free 30-minute consultation.

FAQ

What is a good clean claim rate for a medical practice? Clean claim rate measures the percentage of claims that get paid on first submission with no correction needed. Industry benchmarking bodies like MGMA and HFMA treat rates in the mid-90s and above as strong performance; anything meaningfully lower usually points to front-end data or coding issues rather than payer behavior.

How many days should it take to get a medical claim paid? HFMA’s MAP Keys benchmark net days in AR at 30 to 40 days for a healthy revenue cycle, with fewer than 10% of receivables aged past 90 days. Claims routinely sitting past 60 days are a sign of a bottleneck somewhere in the process.

Why do healthcare claims get denied? Denials trace back to a mix of causes — eligibility and registration errors, coding mistakes, missing prior authorization, and timely-filing misses are among the most common. MGMA’s data shows denial rates have been rising industry-wide, which is why prevention at intake matters more than appeals after the fact.

How much revenue does a specialty practice lose to billing and collection gaps? It varies by practice size and specialty, but the leaks compound: denied claims requiring rework, AR aging past collectible windows, uncredentialed providers who can’t bill, and missed point-of-service collections. A revenue cycle assessment is the only reliable way to size the number for your specific practice.

Reference

Orthopedic Prior Authorization Denials Are Rising — Here’s What the Data Shows

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

Every denied prior authorization is a surgery pushed back, a patient who may not come back, and revenue your practice already staffed for but can’t collect. If that cycle feels like it’s happening more often this year, it’s not your imagination — it’s showing up in the national data too.

Is Prior Authorization Denial Actually Getting Worse?

Yes, and physicians are saying so directly. Three in four physicians (74%) report that denials have increased over the past five years, per the AMA’s 2025 Prior Authorization Physician Survey. On the request side, 86% of medical group leaders told MGMA in a 2025 MGMA Stat poll that prior authorization requirements themselves have increased in the past year — not just denials, but the volume of procedures now requiring approval before you can even schedule them.

For orthopedic practices specifically, this matters more than most specialties. Surgical and imaging-heavy care — the backbone of orthopedic volume — sits squarely in the outpatient category where payers have been tightening review criteria.

What’s Actually Driving the Increase?

Two forces are colliding: more procedures requiring authorization, and less clinical rigor behind the denials themselves. Nearly one in three physicians (32%) report that PA requests are often or always denied, according to the AMA’s 2025 survey. At the same time, only 24% of physicians say medical necessity denials are consistently reviewed by an appropriately qualified clinician, despite payer commitments to do exactly that.

That gap — high denial volume paired with thin clinical review — is why appeals often succeed when practices have the bandwidth to pursue them. The problem is most practices don’t.

What Does This Actually Cost an Orthopedic Practice?

Time, first — and time is money in a fee-for-service model. Physicians complete an average of 40 prior authorizations per week, per the AMA’s 2025 survey, with the 2024 survey putting the associated staff time at roughly 13 hours weekly. That’s a full administrative shift, every week, before a single claim is even submitted.

Then there’s the claims side. Kodiak Solutions’ Revenue Cycle Analytics, which tracks financial data from more than 1,850 hospitals and 250,000 physicians nationwide, found initial prior authorization and precertification denials on outpatient claims rose 16% from 2021 to 2023 — and inpatient claims rose 26% in the same window. Outpatient is where the bulk of orthopedic scheduling lives: imaging, injections, scoped procedures, and elective surgery.

MGMA’s 2026 Regulatory Burden Report adds another layer: 92% of surveyed medical group practices said they’ve had to hire or reassign staff specifically to keep up with prior authorization volume. That’s headcount spent chasing approvals instead of growing the practice.

What Can Practice Owners Actually Do About It?

Start by separating what you can control from what you can’t. You can’t control payer policy. You can control how tightly your intake, coding, and submission process is run before a request ever reaches a payer — because most denials on the front end are procedural, not clinical.

This is where credentialed human oversight matters more than software alone. Automated PA tools can flag missing fields; they can’t catch a payer’s shifting medical-necessity criteria or build the appeal that gets a legitimate case overturned. That takes a specialist who knows the payer, the CPT code, and the clinical documentation standard cold.

That’s the model behind Reviora Healthcare LLC’s approach: Expert-Led Technology, where credentialed specialists — not algorithms — drive every claims and authorization decision, with technology supporting their judgment rather than replacing it. Our orthopedic RCM work is governed by a Managed Outcomes Agreement (MOA) — a written, contractual performance agreement built around specific benchmarks — backed by a Benchmark Recovery Protocol that triggers a root-cause audit and corrective action plan if performance slips two months in a row. It’s accountability built into the contract, not a promise made in a sales call.

If your denial rate has crept up and you’re not sure whether it’s payer behavior or something fixable in your own workflow, that’s worth a real conversation. Book a free 30-minute consultation and we’ll walk through what your numbers are actually telling you.

Related reading: Orthopedic RCM Services | Claims Submission & Denial Management | The Reviora Guarantee

FAQ

Why are prior authorization denials going up for orthopedic practices? Payers have expanded which procedures require authorization while clinical review of denials has grown thinner — only 24% of physicians report denials are consistently reviewed by a qualified clinician, per AMA’s 2025 survey.

How much staff time does prior authorization actually take? Physicians complete an average of 40 PA requests weekly, with roughly 13 hours of associated staff time reported in AMA’s Prior Authorization Physician Survey data.

Are prior authorization denial rates the same across all insurers? No. KFF’s 2025 analysis of standard PA requests found denial rates ranging from 12% to 18% depending on the market segment (Medicare Advantage, Medicaid managed care, and ACA Marketplace).

What can a practice do to reduce denials without adding staff? Tightening front-end intake, coding accuracy, and documentation before submission catches most procedural denials before they happen — which is where a specialist-led RCM partner focuses first.

References

Insurers Promised Licensed Clinicians Would Review Prior Auth Denials — Only 24% Deliver

Posted on by Reviora Healthcare LLC in Newsletter

Reviora Healthcare LLC | Guaranteed Revenue Partner

Every denial letter your practice appeals assumes a basic promise was kept: that someone with actual clinical judgment looked at the case before saying no. New physician-reported data says that assumption fails three times out of four — which means much of the appeal time your staff spends is fighting a decision that was never properly reviewed to begin with.

What Insurers Promised — And What Physicians Say Happened

In June 2025, more than 60 health insurers pledged to reform prior authorization, with one commitment taking effect immediately: all medical necessity denials would be reviewed by a licensed, qualified clinician. Per the 2025 AMA Prior Authorization Physician Survey (a nationwide, web-based survey of 1,000 practicing physicians — 400 primary care, 600 specialists — fielded in December 2025), only 1 in 4 physicians (24%) agree that health plan denials based on medical necessity for clinical factors are being reviewed by a licensed and qualified clinician.

The peer-to-peer step fares worse. Only 16% of physicians participating in peer-to-peer reviews report that the health plan’s “peer” often or always has the appropriate qualifications. Physician confidence in the broader pledge is thin too — only 1 in 3 physicians (33%) believe it’s likely the pledge’s commitments will make a meaningful difference for patients and physicians.

The Weekly Cost to Your Practice

This isn’t just a patient-care statistic — it’s staff hours. Per the same 2025 AMA survey, physicians complete an average of 40 prior authorizations per physician, per week, and physicians and their staff spend an average of 13 hours a week completing them.

Denial volume is also trending the wrong way. Nearly 1 in 3 physicians (32%) report that PAs are often or always denied, and 74% report that PA denials have increased somewhat or significantly over the past five years. The strain compounds: 94% of physicians report that PA somewhat or significantly increases physician burnout. For a lean specialty-clinic billing team, that’s hours diverted from clean-claim work to re-litigating denials against a reviewer who, statistically, may not have been qualified to issue them.

Appeals Often Work — But Know Which Data You’re Standing On

Here’s a real reframe, sourced correctly: KFF’s analysis of Medicare Advantage prior authorization data found that while only 11.7% of Medicare Advantage prior authorization denials were appealed, 81.7% of those appeals achieved complete or partial success in overturning the denial — a figure cited by AMA leadership as evidence that many initial MA denials don’t hold up. That number is specific to Medicare Advantage, not every payer, so treat it as a directional signal, not a universal guarantee.

Meanwhile, the 2025 AMA physician survey shows most physicians still aren’t appealing consistently: 59% say they don’t believe the appeal will succeed based on past experience, 52% cite insufficient staff time, and 49% say patient care can’t wait for approval. That gap — high potential success, low follow-through — is where a systematic, well-documented appeal process pays for itself.

What “Qualified Clinician Review” Is Supposed to Mean

The pledge language sounds simple but hides a real distinction. It means a licensed clinician in the same or a similar specialty — not a generalist reviewer or an algorithm — should evaluate whether a denial for, say, a dermatology biologic or an orthopedic imaging order is clinically justified. When that doesn’t happen, the burden shifts back to your practice to prove medical necessity a second time, in writing.

Where This Leaves Your Practice

This is a structural gap in the payer system, not a billing-team failure — but it still lands on your billing team’s desk. The fix isn’t hoping insurers self-correct; it’s a denial and appeal process disciplined enough to catch and challenge unqualified reviews as routine, not exception.

That’s the model behind Reviora’s Claims Submission & Denial Management service — Expert-Led Technology, where credentialed billing and RCM specialists, not software, drive every denial review and appeal decision. It’s backed by our Managed Outcomes Agreement, a written, contractual performance agreement with a Benchmark Recovery Protocol (BRP) that activates automatically if benchmarks are missed two months running.

If prior auth denials are eating more of your team’s week than they should, a 30-minute conversation can tell you whether the gap is process, staffing, or payer behavior. Book a consultation.

FAQ

Why are insurance companies not reviewing my denials with a real doctor?
Per the 2025 AMA Prior Authorization Physician Survey (1,000 physicians, fielded December 2025), only 24% of physicians agree that medical necessity denials are consistently reviewed by an appropriately qualified, licensed clinician, despite a 2025 industry pledge to do so.

Is it worth appealing a prior authorization denial?
For Medicare Advantage plans specifically, KFF’s analysis found 81.7% of appealed denials were fully or partially overturned — though most physicians still don’t appeal consistently, per AMA survey data, largely due to low expected success and limited staff time.

What does “peer-to-peer review” actually mean in prior auth?
It’s a call between your physician and a payer-side clinician to argue medical necessity directly — but per the 2025 AMA survey, only 16% of physicians say that payer-side reviewer often or always has appropriate qualifications for the case.

How much time does prior authorization actually cost a practice?
Per the 2025 AMA survey, physicians complete an average of 40 prior authorizations per week, and physicians and staff spend about 13 hours weekly on the process.

References

Why Behavioral Health Claims Get Denied More Than Almost Any Other Specialty

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

Every denied claim is a session you already delivered, a clinician you already paid, and revenue you have to fight to collect twice. If you run a behavioral health practice, you already know this fight happens more often than it should — and more often than it does for the orthopedic group down the street.

Is behavioral health actually denied more than other specialties?

The data says yes, structurally. MGMA’s 2023 DataDive Practice Operations dataset put the single-specialty aggregate first-submission denial rate at 8% — a rate that held steady from 2019. Behavioral health routinely runs above that baseline, and it’s not because your billing team is worse at their job.

It’s because behavioral health claims carry review requirements most specialties never touch: concurrent authorization for ongoing levels of care, session-count scrutiny past an arbitrary threshold, and “medical necessity” criteria that shift by payer. A clean claim in orthopedics stays clean. A clean claim in behavioral health can get re-reviewed mid-treatment. See how Reviora structures denial prevention for behavioral health practices →

Why does “medical necessity” cause so many denials here?

Because it’s the one determination payers apply more subjectively to behavioral health than to almost anything else. Physical medicine has objective markers — imaging, labs, wound measurements. Behavioral health has clinical judgment, and payers know that judgment is harder to defend claim-by-claim.

This is also where prior authorization does the most damage. The AMA’s 2024 Prior Authorization Physician Survey found physicians complete an average of 39 prior authorizations per week, consuming roughly 13 hours of physician and staff time — and nearly 1 in 3 physicians (31%) report those requests are often or always denied outright. Behavioral health, with its concurrent-review model, absorbs more of that cycle than most specialties because the authorization isn’t a one-time gate. It’s a recurring checkpoint your team has to clear every few sessions.

The cost of that checkpoint is measurable. CAQH’s 2024 Index Report found a manually processed prior authorization costs providers an average of $3.41 per transaction and takes about 24 minutes of staff time when handled by phone, fax, or email — compared to $0.05 and a fraction of the time when done electronically. For a behavioral health practice running concurrent reviews every few sessions across a full caseload, that gap compounds fast.

Doesn’t federal parity law prevent this?

It’s supposed to — and it doesn’t fully. The Mental Health Parity and Addiction Equity Act (MHPAEA) requires insurers to apply the same coverage standards to behavioral health as they do to medical and surgical care. In practice, a 2019 Milliman analysis of claims data covering more than 37 million people found the disparity in how often behavioral health inpatient care gets pushed out-of-network relative to medical/surgical care had grown 85% over the prior study period — evidence that payers still treat behavioral health differently on the ground, parity law notwithstanding.

MHPAEA restricts how payers can write their policies. It doesn’t stop a reviewer from disputing whether session 14 was still “medically necessary.” That gap is where your denials live.

Is this trend getting better or worse?

Worse, industry-wide. A March 2024 MGMA Stat poll found 60% of medical group leaders reported their claim denial rates increasing year over year — and only 11% had successfully brought their rates back down. Behavioral health practices, layering concurrent review and prior auth burden on top of that industry trend, are absorbing more than their share of that gap. See the full Reviora Guarantee framework →

What actually closes the gap?

Not appealing harder after the fact — fixing the workflow before the claim goes out. Practices that hold denial rates near the industry floor connect clinical documentation directly to coding before submission, track authorization windows proactively instead of reactively, and treat concurrent review as a scheduled task, not a surprise.

That’s the structural problem Reviora Healthcare is built to solve. Every Reviora client works under a Managed Outcomes Agreement — a written, contractual performance framework, not a marketing promise — with a Benchmark Recovery Protocol that activates automatically if performance on any core benchmark misses target two months in a row. Credentialed specialists lead every decision on your account; technology supports their work, it doesn’t replace their judgment. That’s what “Expert-Led Technology” means at Reviora. Learn more about our behavioral health billing and denial management process →

If your denial rate feels high and you’re not sure whether it’s normal for behavioral health or a fixable process gap, a 30-minute conversation will usually answer that question. Book a consultation →

FAQ

Why do behavioral health claims get denied more than medical claims?
Behavioral health relies on subjective medical necessity criteria and recurring concurrent review, while most other specialties are approved once and billed. That structural difference produces more denial opportunities per episode of care.

What’s a normal denial rate for a medical practice?
MGMA’s most recent DataDive benchmark puts the single-specialty aggregate first-submission denial rate at 8%. Behavioral health practices with strong documentation-to-coding workflows can approach that floor; those without it typically run well above it.

Does mental health parity law stop insurance companies from denying claims more often?
No. MHPAEA requires equal coverage standards, but it doesn’t prevent a payer from disputing medical necessity on a case-by-case basis — which is where most behavioral health denials originate.

How can I lower my practice’s behavioral health denial rate?
Start by auditing where clinical documentation and coding disconnect, and by tracking every authorization window proactively rather than reacting to denials after they happen. A revenue cycle partner with behavioral-health-specific processes can usually diagnose this in a short review.

Reference

  • MGMA DataDive Practice Operations (2023)
  • MGMA Stat poll (March 2024)
  • AMA 2024 Prior Authorization Physician Survey
  • CAQH 2024 Index Report
  • Milliman, Addiction and Mental Health vs. Physical Health
  • Widening Disparities in Network Use and Provider Reimbursement (2019)
  • U.S. Department of Labor, MHPAEA

Why Your Practice’s Claim Denial Rate Is Climbing in 2026 — And What the HFMA Benchmark Actually Means

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

If your billing team feels like they’re fighting more claims than they used to, they are. It’s not your coders getting sloppier — it’s the rules changing faster than most practices can track, and every denied claim is 30-60 days of cash flow you were counting on.

Here’s what’s actually happening, and where your numbers should sit.

Why Is My Denial Rate Going Up in 2026?

Three things are converging at once, and none of them are your billing team’s fault. Payers have tightened prior authorization enforcement, coding edit tables have changed, and adjudication software is flagging claims that would have sailed through two years ago.

This isn’t a perception problem. A recent MGMA Stat poll found that 60% of medical group leaders reported an increase in their practice’s claim denial rate — and only 11% had managed to bring their rate back down. That gap is the real story: most practices know denials are rising, but few have a structured process to reverse it.

Separately, MGMA’s benchmarking research on denials and appeals found that more than half of healthcare organizations now report denial rates exceeding 10% — double the top of HFMA’s acceptable range. Add in AMA’s 2024 Prior Authorization Physician Survey, which found physicians and staff spend an average of 13 hours per week per physician just processing authorization requests, and it’s clear: the administrative load behind every clean claim has gone up, even when nothing in your practice changed.

What Does the HFMA Benchmark Actually Say?

HFMA — the industry’s standard-setting body for revenue cycle metrics — considers a denial rate of 5% to 10% acceptable, with anything under 5% considered optimal performance. That’s the line, not a moving target and not a sales pitch. It’s the same MAP Keys framework hospitals, health systems, and physician groups are all measured against.

For context on where the industry actually sits: revenue cycle data from Kodiak Solutions, drawn from more than 2,100 hospitals and 300,000 physicians, shows the average initial denial rate climbed to 11.8% in 2024 — already above HFMA’s acceptable ceiling before 2025 and 2026 pressures compounded it further. If your practice is tracking anywhere close to that number, you’re not an outlier. You’re the norm right now, which is exactly the problem.

What Is This Actually Costing You?

Every denied claim doesn’t just delay payment — it consumes staff hours you’re already short on. Between prior authorization volume and appeals, front-office and billing staff are spending time on rework instead of revenue-generating work, and that labor cost rarely shows up on the P&L line labeled “denials.”

The slower cost is Days in AR creeping upward, month over month, until it’s normalized. A denial rate that sits at 10-12% doesn’t just cost the denied dollars — it drags down every other cash flow metric attached to it.

How Do You Get Back Under Benchmark?

his is where most practices try to solve a systems problem with more staff hours, and it doesn’t hold. The fix isn’t working denials harder after they happen — it’s closing the gaps that create them before a claim is ever submitted.

At Reviora, this is built into how we operate, not something we bolt on. Our team runs on Expert-Led Technology — credentialed billing and coding specialists lead every claim decision, using technology as a tool to catch what a payer will flag, not as a replacement for judgment. Every client engagement runs under a Managed Outcomes Agreement (MOA) — a written, contractual performance agreement built around defined benchmarks, including a denial rate target under 5%, matching HFMA’s optimal range rather than just its acceptable floor.

If a benchmark is missed two months in a row, our Benchmark Recovery Protocol (BRP) activates automatically — see What Happens If We Miss — a defined accountability process, not a vague promise to “look into it.”

If denial management specifically is your pain point, our Claims Submission & Denial Management page walks through how we structure that work day to day.

If your denial rate has been climbing and you’re not sure why, a second set of eyes on your claims data is usually the fastest way to find out. Book a free 30-minute consultation and we’ll walk through where your practice actually stands against benchmark. Not ready to talk yet? See what to expect from a first conversation before you reach out.

FAQ

What is a good claim denial rate for a medical practice? Per HFMA’s MAP Keys benchmark, 5-10% is considered acceptable, and under 5% is optimal. Above 10% signals a process gap worth investigating.

Why are claim denials increasing in 2026? Tighter prior authorization enforcement, updated payer coding edits, and more aggressive automated claims review are the main drivers, per MGMA and AMA survey data.

How do I lower my practice’s denial rate? Focus on the front end — eligibility verification, authorization matching, and clean coding before submission — since most denials are prevented, not appealed. A structured denial management process outperforms after-the-fact appeals.

Is a 10% denial rate bad? Yes — it’s above HFMA’s acceptable ceiling of 10% and roughly in line with the national average AHA reported for 2024 (11.8%), meaning a 10%+ rate puts a practice at or below where the broader industry already struggles.

Reference